Literature DB >> 16441958

Force-dependent static dead space of face masks used with holding chambers.

Samir A Shah1, Ariel B Berlinski, Bruce K Rubin.   

Abstract

BACKGROUND: Pressurized metered-dose inhalers with valved holding chambers and masks are commonly used for aerosol delivery in children. Drug delivery can decrease when the dead-space volume (DSV) of the valved holding chamber is increased, but there are no published data evaluating force-dependent DSV among different masks.
METHODS: Seven masks were studied. Masks were sealed at the valved holding chamber end and filled with water to measure mask volume. To measure mask DSV we used a mannequin of 2-year-old-size face and we applied the mask with forces of 1.5, 3.5, and 7 pounds. Mask seal was determined by direct observation. Intra-brand analysis was done via analysis of variance.
RESULTS: At 3.5 pounds of force, the DSV ranged from 29 mL to 100 mL, with 3 masks having DSV of < 50 mL. The remaining masks all had DSV > 60 mL. At 3.5 pounds of force, DSV percent of mask volume ranged from 33.7% (Aerochamber, p < 0.01 compared with other masks) to 100% (Pocket Chamber). DSV decreased with increasing force with most of the masks, and the slope of this line was inversely proportional to mask flexibility. Mask fit was 100% at 1.5 pounds of force only with the Aerochamber and Optichamber. Mask fit was poorest with the Vortex, Pocket Chamber, and BreatheRite masks.
CONCLUSION: Rigid masks with large DSV might not be not suitable for use in children, especially if discomfort from the stiff mask makes its use less acceptable to the child.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441958

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  8 in total

1.  Bioavailability of inhaled fluticasone propionate via chambers/masks in young children.

Authors:  K Blake; R Mehta; T Spencer; R L Kunka; L Hendeles
Journal:  Eur Respir J       Date:  2011-09-20       Impact factor: 16.671

Review 2.  Innovative preclinical models for pulmonary drug delivery research.

Authors:  Stephan Ehrmann; Otmar Schmid; Chantal Darquenne; Barbara Rothen-Rutishauser; Josue Sznitman; Lin Yang; Hana Barosova; Laurent Vecellio; Jolyon Mitchell; Nathalie Heuze-Vourc'h
Journal:  Expert Opin Drug Deliv       Date:  2020-02-23       Impact factor: 6.648

3.  Developing ways to evaluate in the laboratory how inhalation devices will be used by patients and care-givers: the need for clinically appropriate testing.

Authors:  Jolyon P Mitchell; Jason A Suggett
Journal:  AAPS PharmSciTech       Date:  2014-06-04       Impact factor: 3.246

4.  More Realistic Face Model Surface Improves Relevance of Pediatric In-Vitro Aerosol Studies.

Authors:  Israel Amirav; Asaf Halamish; Miguel Gorenberg; Hamza Omar; Michael T Newhouse
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

5.  Feasibility of aerosol drug delivery to sleeping infants: a prospective observational study.

Authors:  Israel Amirav; Michael T Newhouse; Anthony Luder; Asaf Halamish; Hamza Omar; Miguel Gorenberg
Journal:  BMJ Open       Date:  2014-03-26       Impact factor: 2.692

Review 6.  Optimal administration of bronchodilators with valved holding chambers in preschool children: a review of literature.

Authors:  Péter Csonka; Terhi Tapiainen; Mika J Mäkelä; Lauri Lehtimäki
Journal:  Eur J Pediatr       Date:  2021-04-20       Impact factor: 3.183

7.  Assessing Modeled CO(2) Retention and Rebreathing of a Facemask Designed for Efficient Delivery of Aerosols to Infants.

Authors:  Christian Mundt; Alexander Sventitskiy; Jeffrey E Cehelsky; Andrea B Patters; Markus Tservistas; Michael C Hahn; Gerd Juhl; John P Devincenzo
Journal:  ISRN Pediatr       Date:  2012-06-26

Review 8.  A review of the in vitro and in vivo valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHC.

Authors:  Sanjeeva Dissanayake; Jason Suggett
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.